Dr. Burger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000Fax+1 904-953-2082
Summary
- Dr. Charles Burger is a pulmonologist in Jacksonville, FL and is affiliated with Mayo Clinic Hospital in Florida. He received his medical degree from Wake Forest School of Medicine and has been in practice 32 years. He specializes in pulmonary vascular medicine and is experienced in pulmonary hypertension and lymphangioleiomyomatosis.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1991
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1985 - 1988
- Bowman Gray School of MedicineMD, 1982 - 1985
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1985
- University of TennesseeBA, Chemistry, Academic Scholarship, Graduated with High Honors, 1978 - 1981
Certifications & Licensure
- FL State Medical License 1990 - 2025
- GA State Medical License 2013 - 2017
- KY State Medical License 2014 - 2016
- MN State Medical License 1999 - 2004
- IA State Medical License 1988 - 1991
- TN State Medical License 1987 - 1991
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Top Doctor Castle Connolly, 2013-2024
- Mayo Clinic School of Continuous Professional Development Award of Distinction Mayo Clinic School of Continuous Professional Development, 2023
- Team Innovation Award Mayo Clinic Department of Medicine, 2023
- Join now to see all
Clinical Trials
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
- Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension Start of enrollment: 2008 Oct 17
- Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 124 citationsPhase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.Marius M Hoeper, David B Badesch, H Ardeschir Ghofrani, J Simon R Gibbs, Mardi Gomberg-Maitland
The New England Journal of Medicine. 2023-04-20 - 880 citationsMacitentan and morbidity and mortality in pulmonary arterial hypertension.Tomás Pulido, Igor Adzerikho, Richard N. Channick, Marion Delcroix, Nazzareno Galiè
The New England Journal of Medicine. 2013-08-28 - 367 citationsPredicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L. Benza, Mardi Gomberg-Maitland, C. Greg Elliott, Harrison W. Farber, Aimee J. Foreman
Chest. 2019-08-01
Journal Articles
- Pulmonary Arterial Stiffness Assessed by Cardiovascular Magnetic Resonance Imaging Is a Predictor of Mild Pulmonary Arterial HypertensionRobert Safford, Christopher Austin, Charles Burger, Jordan C Ray, Joseph Blackshear, Brian Shapiro, Patricia Mergo, The International Journal of Cardiovascular Imaging
- Recent updates in the both the diagnosis and treatment options that impact the clinical treatment of pulmonary arterial hypertension.Burger CD, Clinical Medicine Insights: Therapeutics 2:291-7
- Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY.Kitterman N, Poms A, Miller DP, Lombardi S, Farber HW, Barst RJ, Mayo Clin Proc 87(9):825-834
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Brain natriuretic peptide as a measure of therapeutic responsiveness in a heterogeneous group of patients with pulmonary hypertension.Gisel JJ, McNeil RB, Burger CD, Am J Respir Crit Care Med A923
- Sleep patterns of cyclic parenteral nutrition. Are there sleepless nights?Savoy A, Scolapio JS, Kaplan J, Burger CD, Lin SC, Gastroenterology 122:M1832
- Response to Bronchodilator (BD) in Patients with Lymphangioleiomyomatosis (LAM) – A retrospective Analysis.Yen KT, Staats BA, Burger CD, Am J Resp Crit Care Med 165: A153
- Join now to see all
Lectures
- 2013 A Multidisciplinary Update in Pulmonary and Critical Care MedicineMayo School of Continuous Professional Development, Scottsdale, Arizona - 4/11/2013
- Pulmonary Hypertension in COPD.Complications of COPD Conference Jacksonville, Florida
- Fungal Infections in the Critically Ill.North Florida Regional Center Lake Butler, Florida
- Join now to see all
Press Mentions
- I'm Aware That I'm Rare: The Phaware® PodcastAugust 13th, 2024
- Inhaled Treprostinil Improves Persistence, Lowers Risk for PAH Hospitalization vs. IloprostJune 9th, 2022
- Did Black Patients with COVID-19 See Greater Benefits with Novel Mab Therapy?April 24th, 2022
- Join now to see all
Committees
- Member, Pulmonary Hypertension Association Registry (PHAR) Steering Committee 2019 - Present
- Editor in Chief, Advances in Pulmonary Hypertension journal editorial board 2015 - 2017
- Chair, 2014 PHAssociation International Meeting Program Committee 2012 - 2014
- Member, Scientific Leadership Council Pulmonary Hypertension Association 2011 - 2015
Professional Memberships
- Fellow
- Fellow
- Member
External Links
- Mayo Clinic Biohttp://www.mayoclinic.org/10478931.html
- Mayo Clinic Researchhttp://mayoresearch.mayo.edu/mayo/research/staff/burger
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: